NRG
AVNS

Nemes Rush Group’s Avanos Medical AVNS Stock Holding History

Nemes Rush Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$715 Hold
51
– – ﹤0.01% 853
2025
Q4 		$573 Hold
51
– – ﹤0.01% 860
2025
Q3 		$590 Hold
51
– – ﹤0.01% 656
2025
Q2 		$624 Hold
51
– – ﹤0.01% 681
2025
Q1 		$731 Hold
51
– – ﹤0.01% 666
2024
Q4 		$812 Hold
51
– – ﹤0.01% 671
2024
Q3 		$1.01K Hold
51
– – ﹤0.01% 546
2024
Q2 		$1.02K Hold
51
– – ﹤0.01% 555
2024
Q1 		$1.02K Hold
51
– – ﹤0.01% 603
2023
Q4 		$1.14K Hold
51
– – ﹤0.01% 587
2023
Q3 		$1.03K Sell
51
-26
-34% -$589 ﹤0.01% 583
2023
Q2 		$1.97K Buy
+77
New +$2.03K ﹤0.01% 570

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Nemes Rush Group's AVNS Position: Q1 2026 in Review

Nemes Rush Group held its Avanos Medical (AVNS) position steady in Q1 2026 at 51 shares worth $715. The position accounts for ﹤0.01% of the portfolio, ranked #853.

Nemes Rush Group first reported a position in AVNS in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.97K in Q2 2023. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Nemes Rush Group held 51 shares of Avanos Medical worth $715 as of Q1 2026.
  • Nemes Rush Group left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Nemes Rush Group's portfolio in Q1 2026, its #853 holding.
  • Nemes Rush Group first reported a position in Avanos Medical in Q2 2023 and has held it in 12 quarters since.
  • Nemes Rush Group's Avanos Medical position peaked at $1.97K in Q2 2023.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.